MEDICAID: KIDNEY DISEASE H.B. 5063 (S-1): FLOOR ANALYSIS
House Bill 5063 (Substitute S-1 as reported)
Sponsor: Representative John Gleason
House Committee: Health Policy
Senate Committee: Health Policy
CONTENT
The bill would amend the Social Welfare Act to permit individuals enrolled in the Medicaid program to receive screening; laboratory, diagnostic, and early intervention services; and treatment for chronic kidney disease pursuant to guidelines established by the Department of Community Health.
Additionally, the bill would require a clinical laboratory performing a creatinine test on a Medicaid enrollee to include in the lab report the person's glomerular filtration rate and report it as a percent of kidney function remaining.
MCL 400.109 Legislative Analyst: Julie Koval
FISCAL IMPACT
Victims of kidney disease who are Medicaid-eligible are already covered for the services specified in the bill. Therefore, the bill would have no fiscal impact. The creatinine reporting requirement is current Medicaid policy and would have no impact.
Date Completed: 3-2-06 Fiscal Analyst: Steve Angelotti
Analysis was prepared by nonpartisan Senate staff for use by the Senate in its deliberations and does not constitute an official statement of legislative intent. hb5063/0506